FIVE-YEAR REVOLVING CREDIT FACILITY CREDIT AGREEMENT Dated as of January 12, 2012 among GILEAD SCIENCES, INC., as Borrower, GILEAD BIOPHARMACEUTICS IRELAND CORPORATION, as Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and...Credit Agreement • January 17th, 2012 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 17th, 2012 Company Industry JurisdictionThis FIVE-YEAR REVOLVING CREDIT FACILITY CREDIT AGREEMENT (as amended, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”) is entered into as of January 12, 2012 among GILEAD SCIENCES, INC., a Delaware corporation (the “Parent”), GILEAD BIOPHARMACEUTICS IRELAND CORPORATION, an Irish company (“Gilead Ireland”; Gilead Ireland together with the Parent are together referred to as the “Borrowers”, and each individually, as a “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and each individually, a “Lender”) and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.
PARENT GUARANTY AGREEMENT (SHORT-TERM REVOLVING CREDIT FACILITY)Parent Guaranty Agreement • January 17th, 2012 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 17th, 2012 Company Industry JurisdictionThis PARENT GUARANTY AGREEMENT, dated as of January 12, 2012 (this “Agreement”), is made by GILEAD SCIENCES, INC., a Delaware corporation (the “Parent” or “Guarantor”), in favor of BANK OF AMERICA, N.A., as administrative agent (in such capacity, and together with its successors and assigns in such capacity, the “Administrative Agent”) for each of the Credit Parties (as defined below).
TERM LOAN FACILITY CREDIT AGREEMENT Dated as of January 12, 2012 among GILEAD SCIENCES, INC., as Borrower, BANK OF AMERICA, N.A., as Administrative Agent, The Other Lenders Party Hereto, BARCLAYS CAPITAL, as Syndication Agent and GOLDMAN SACHS BANK...Term Loan Facility Credit Agreement • January 17th, 2012 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 17th, 2012 Company Industry JurisdictionThis TERM LOAN FACILITY CREDIT AGREEMENT (as amended, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”) is entered into as of January 12, 2012 among GILEAD SCIENCES, INC., a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and each individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent.
SHORT-TERM REVOLVING CREDIT FACILITY CREDIT AGREEMENT Dated as of January 12, 2012 among GILEAD SCIENCES, INC., as Borrower, GILEAD BIOPHARMACEUTICS IRELAND CORPORATION, as Borrower, BANK OF AMERICA, N.A., as Administrative Agent, The Other Lenders...Short-Term Revolving Credit Facility Credit Agreement • January 17th, 2012 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 17th, 2012 Company Industry JurisdictionThis SHORT-TERM REVOLVING CREDIT FACILITY CREDIT AGREEMENT (as amended, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”) is entered into as of January 12, 2012 among GILEAD SCIENCES, INC., a Delaware corporation (the “Parent”), GILEAD BIOPHARMACEUTICS IRELAND CORPORATION, an Irish company (“Gilead Ireland”; Gilead Ireland together with the Parent are together referred to as the “Borrowers”, and each individually, as a “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and each individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent.